Research into targeted therapies for melanoma is ongoing, and Melan A has potential as a target for immunotherapy. Vaccines or T-cell therapies designed to target Melan A-expressing cells could provide a new avenue for treating melanoma. Clinical trials are investigating these possibilities, although they are not yet standard treatments.
